Kyverna Therapeutics Inc. COM is a security (CUSIP 501976104) tracked across SEC portfolio filings. 117 institutional managers reported $316.9M on Form 13F as of 2026-06-30; 7 registered fund positions totaling $14.4M via N-PORT as of 2026-03-31.
Showing 15 of 117 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| GILEAD SCIENCES, INC. | FOSTER CITY, CA | $36.8M | 4,126,119 |
| GordonMD Global Investments LP | Beverely Hills, CA | $36.6M | 4,244,818 |
| Vida Ventures Advisors, LLC | Boston, MA | $27.1M | 4,523,924 |
| Bain Capital Life Sciences Investors, LLC | Boston, MA | $26.8M | 3,110,000 |
| AIGH Capital Management LLC | BALTIMORE, MD | $17.3M | 2,000,000 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | New York, NY | $17.3M | 2,000,000 |
| VANGUARD GROUP INC | Valley Forge, PA | $16.7M | 1,781,257 |
| Balyasny Asset Management L.P. | Chicago, IL | $9.7M | 1,125,321 |
| MILLENNIUM MANAGEMENT LLC | NEW YORK, NY | $8.7M | 1,005,508 |
| Insight Holdings Group, LLC | NEW YORK, NY | $8.5M | 989,054 |
| MORGAN STANLEY | NEW YORK, NY | $8.4M | 977,289 |
| BlackRock, Inc. | New York, NY | $7.6M | 877,078 |
| Woodline Partners LP | San Francisco, CA | $7.3M | 845,325 |
| D. E. Shaw & Co., Inc. | New York, NY | $6.2M | 721,581 |
| Propel Bio Management, LLC | LOS ANGELES, CA | $5.6M | 644,421 |
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| T. Rowe Price Health Sciences Fund, Inc. | T. ROWE PRICE HEALTH SCIENCES FUND, INC. | $9.9M | 9.05% |
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $3.4M | 0.42% |
| T. Rowe Price Health Sciences Portfolio | T. ROWE PRICE EQUITY SERIES, INC. | $696K | 10.51% |
| VANGUARD BALANCED INDEX FUND | VANGUARD VALLEY FORGE FUNDS | $194K | 0.03% |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | VANGUARD INSTITUTIONAL INDEX FUNDS | $146K | 0.05% |
| Federated Hermes Managed Volatility Fund II | Federated Hermes Insurance Series | $104K | 6.07% |
| Blackstone Alternative Multi-Strategy Fund | Blackstone Alternative Investment Funds | $7K | 0.02% |